High-throughput screening is a reliable method for discovering compounds that interact with novel therapeutic targets to improve human health. “Nuisance compounds” interfere with drug discovery by confounding screening results.
Mycobacterium abscessus is an opportunistic pathogen that causes severe lung infections, particularly in patients with underlying lung disorders such as cystic fibrosis or chronic pulmonary disease and is intrinsically resistant to most antibiotics. The high pH in the airway lumen environment serves as a natural barrier, in
Drs. Gunda Georg and Vadim Gurvich will co-lead the contract.
The Biruta K. and Peter A. Olstein Fellowship is awarded to a full-time CoP PhD graduate student with exceptional potential in their field.
Dr. Carrie Haskell-Luevano loves being a researcher. As a professor and Philip S. Portoghese Endowed Chair in Chemical Neuroscience, she finds joy in teaching students and making discoveries alongside her laboratory staff. Read about the value she finds in her partnership with UMN Technology Commercialization.
New role becomes effective July 18, 2022.